| Date Checked | 2026-06-19 21:51:25 |
|---|---|
| Graham Number | (PB)68.52 vs (PE)64.55 |
| Over / Under Value Percentage | 187.41% vs 193.20% |
| Dividend Yield | 0.00% |
| Dividend Date | 2026-03-23 |
| Symbol | AZN |
| AssetType | Common Stock |
| Name | AstraZeneca PLC |
| Description | AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections, neuroscience and gastroenterology worldwide. The company is headquartered in Cambridge, the United Kingdom. |
| CIK | 901832 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | DRUG MANUFACTURERS - GENERAL |
| Address | 1 FRANCIS CRICK AVENUE, CAMBRIDGE, UNITED KINGDOM, CB2 0AA |
| OfficialSite | https://www.astrazeneca.com |
| FiscalYearEnd | December |
| LatestQuarter | 2026-03-31 |
| MarketCapitalization | 287112495000 |
| EBITDA | 19279999000 |
| PERatio | 27.85 |
| PEGRatio | 1.537 |
| BookValue | 31.38 |
| DividendPerShare | 0 |
| EPS | 6.65 |
| RevenuePerShareTTM | 37.9 |
| ProfitMargin | 0.174 |
| OperatingMarginTTM | 0.216 |
| ReturnOnAssetsTTM | 0.0819 |
| ReturnOnEquityTTM | 0.228 |
| RevenueTTM | 58738999000 |
| GrossProfitTTM | 47993000000 |
| DilutedEPSTTM | 6.65 |
| QuarterlyEarningsGrowthYOY | 0.539 |
| QuarterlyRevenueGrowthYOY | 0.041 |
| AnalystTargetPrice | 223.89 |
| AnalystRatingStrongBuy | 2 |
| AnalystRatingBuy | 6 |
| AnalystRatingHold | 1 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | 27.85 |
| ForwardPE | 17.99 |
| PriceToSalesRatioTTM | 4.888 |
| PriceToBookRatio | 6.07 |
| EVToRevenue | 5.19 |
| EVToEBITDA | 15.56 |
| Beta | 0.275 |
| 52WeekHigh | 210.5 |
| 52WeekLow | 130.04 |
| 50DayMovingAverage | 196.94 |
| 200DayMovingAverage | 176.83 |
| SharesOutstanding | 1550284000 |
| SharesFloat | 1543371000 |
| PercentInsiders | 0.042 |
| PercentInstitutions | 58.547 |
| ExDividendDate | 2026-02-20 |
| naga | 0 |
| etoro | 1 |
| dateChecked | 2026-06-19 21:51:25 |
| fresh | 1 |